2025
Hepatitis C Virus (HCV) Clearance Cascade for Persons With Human Immunodeficiency Virus (HIV)/HCV Coinfection Using Health Department Surveillance Data Among 7 US Jurisdictions Highlights the Role of HIV Care Engagement
Wegener M, Brooks R, Nichols L, Altice F, Villanueva M. Hepatitis C Virus (HCV) Clearance Cascade for Persons With Human Immunodeficiency Virus (HIV)/HCV Coinfection Using Health Department Surveillance Data Among 7 US Jurisdictions Highlights the Role of HIV Care Engagement. Open Forum Infectious Diseases 2025, 12: ofaf412. PMID: 40799793, PMCID: PMC12342353, DOI: 10.1093/ofid/ofaf412.Peer-Reviewed Original ResearchHuman immunodeficiency virusHepatitis C virusDirect-acting antiviralsHepatitis C virus outcomeImmunodeficiency virusHuman immunodeficiency virus care engagementHuman immunodeficiency virus viral suppressionC virusHepatitis C virus monoinfectionHCV-monoinfected individualsHepatitis C virus care continuumCare engagementHIV care engagementHCV clearanceCoinfected populationHealth department jurisdictionsViral suppressionBlack/African American personsPublic health strategiesStudy endMultivariate analysisPublic health infrastructureRisk factorsClinical modelCare continuum
2019
Staying hepatitis C negative: A systematic review and meta‐analysis of cure and reinfection in people who inject drugs
Latham NH, Doyle JS, Palmer AY, Vanhommerig JW, Agius P, Goutzamanis S, Li Z, Pedrana A, Gottfredsson M, Bouscaillou J, Luhmann N, Mazhnaya A, Altice FL, Saeed S, Klein M, Falade‐Nwulia O, Aspinall E, Hutchinson S, Hellard ME, Sacks‐Davis R. Staying hepatitis C negative: A systematic review and meta‐analysis of cure and reinfection in people who inject drugs. Liver International 2019, 39: 2244-2260. PMID: 31125496, DOI: 10.1111/liv.14152.Peer-Reviewed Original ResearchConceptsSustained viral responseDirect-acting antiviralsRecent PWIDOST recipientsTreatment discontinuationPerson yearsReinfection rateRelative riskTreatment outcomesSystematic reviewIncidence of reinfectionTreatment discontinuation ratesPooled relative riskHepatitis C treatmentNewcastle-Ottawa ScaleMixed effects linear modelTherapy recipientsDiscontinuation ratesHepatitis C.Pooled incidenceViral responseCure rateRecent injectingStudy qualityPWID
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply